Leukemia, Lymphocytic, Acute, L1

Known as: Pediatric ALL, Pediatric Acute Lymphoid Leukemia, pediatric leukemia, acute lymphocytic 
When the disease process is confined to a mass lesion with no or minimal evidence of blood and less than 25% marrow involvement, the diagnosis is… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Pediatric acute lymphoblastic leukemia (ALL) is a heterogeneous disease consisting of distinct clinical and biological subtypes… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Prophylactic cranial irradiation has been a standard treatment in children with acute lymphoblastic leukemia (ALL) who… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
We examined the leukemic stem cell potential of blasts at different stages of maturation in childhood acute lymphoblastic… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Cross-sectional studies show that cardiac abnormalities are common in long-term survivors of doxorubicin-treated… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Contemporary treatment of pediatric acute lymphoblastic leukemia (ALL) requires the assignment of patients to specific risk… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2003
Review
2003
Detection of minimal residual disease (MRD) has proven to provide independent prognostic information for treatment stratification… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Treatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept of tailoring the intensity of therapy to a… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Trial ALL-BFM 90 was designed to improve outcome in patients with childhood acute lymphoblastic leukemia (ALL) by using a reduced… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The Janus family of tyrosine kinases (JAK) plays an essential role in development and in coupling cytokine receptors to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1994
Highly Cited
1994
In trial ALL-BFM 86, the largest multicenter trial of the Berlin-Frankfurt-Münster (BFM) study group for childhood acute… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
  • figure 3
Is this relevant?